391 related articles for article (PubMed ID: 29431560)
21. Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development.
Yao Y; Li F; Huang J; Jin J; Wang H
Exp Hematol Oncol; 2021 Jul; 10(1):39. PubMed ID: 34246314
[TBL] [Abstract][Full Text] [Related]
22. Role of CXCR4 Antagonist in Megakaryocyte Reinstatement with Increased Sinusoidal Vessel Density.
Lee JY; Han AR; Hwang HS; Kim DC; Min WS; Kim HJ
Adv Exp Med Biol; 2018; 1072():419-422. PubMed ID: 30178381
[TBL] [Abstract][Full Text] [Related]
23. The Bone Marrow Niche in B-Cell Acute Lymphoblastic Leukemia: The Role of Microenvironment from Pre-Leukemia to Overt Leukemia.
Dander E; Palmi C; D'Amico G; Cazzaniga G
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922612
[TBL] [Abstract][Full Text] [Related]
24. High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
Gerby B; Veiga DF; Krosl J; Nourreddine S; Ouellette J; Haman A; Lavoie G; Fares I; Tremblay M; Litalien V; Ottoni E; Kosic M; Geoffrion D; Ryan J; Maddox PS; Chagraoui J; Marinier A; Hébert J; Sauvageau G; Kwok BH; Roux PP; Hoang T
J Clin Invest; 2016 Dec; 126(12):4569-4584. PubMed ID: 27797342
[TBL] [Abstract][Full Text] [Related]
25. Preservation of Quiescent Chronic Myelogenous Leukemia Stem Cells by the Bone Marrow Microenvironment.
Shah M; Bhatia R
Adv Exp Med Biol; 2018; 1100():97-110. PubMed ID: 30411262
[TBL] [Abstract][Full Text] [Related]
26. Cancer Stem Cells in the Development of Novel Therapeutics for Refractory Pediatric Leukemia.
Brennan L; Narendran A
Stem Cells Dev; 2019 Oct; 28(19):1277-1287. PubMed ID: 31364487
[TBL] [Abstract][Full Text] [Related]
27. The role of microenvironment and immunity in drug response in leukemia.
Bakker E; Qattan M; Mutti L; Demonacos C; Krstic-Demonacos M
Biochim Biophys Acta; 2016 Mar; 1863(3):414-426. PubMed ID: 26255027
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow microenvironment modulation of acute lymphoblastic leukemia phenotype.
Moses BS; Slone WL; Thomas P; Evans R; Piktel D; Angel PM; Walsh CM; Cantrell PS; Rellick SL; Martin KH; Simpkins JW; Gibson LF
Exp Hematol; 2016 Jan; 44(1):50-9.e1-2. PubMed ID: 26407636
[TBL] [Abstract][Full Text] [Related]
29. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
30. A potential area of use for immune checkpoint inhibitors: Targeting bone marrow microenvironment in acute myeloid leukemia.
Aru B; Pehlivanoğlu C; Dal Z; Dereli-Çalışkan NN; Gürlü E; Yanıkkaya-Demirel G
Front Immunol; 2023; 14():1108200. PubMed ID: 36742324
[TBL] [Abstract][Full Text] [Related]
31. [Pathomorphosis of acute leukemia].
Popov VM
Sov Med; 1991; (9):15-8. PubMed ID: 1724709
[TBL] [Abstract][Full Text] [Related]
32. The Bone Marrow Niche - The Tumor Microenvironment That Ensures Leukemia Progression.
Cardoso BA
Adv Exp Med Biol; 2020; 1219():259-293. PubMed ID: 32130704
[TBL] [Abstract][Full Text] [Related]
33. The bone marrow microenvironment in health and disease at a glance.
Kumar R; Godavarthy PS; Krause DS
J Cell Sci; 2018 Feb; 131(4):. PubMed ID: 29472498
[TBL] [Abstract][Full Text] [Related]
34. Identification of leukemia stem cells in acute myeloid leukemia and their clinical relevance.
Hoang VT; Zepeda-Moreno A; Ho AD
Biotechnol J; 2012 Jun; 7(6):779-88. PubMed ID: 22588704
[TBL] [Abstract][Full Text] [Related]
35. Differential chemosensitivity of leukemic cells in the myeloid and lymphoid phases of stem cell leukemia (a case report).
Mihál V; Hajdúch M; Dusek J; Jarosová M; Weigl E; Pikalová Z; Indrák K; Safárová M; Janostáková A
Neoplasma; 1997; 44(2):133-6. PubMed ID: 9201294
[TBL] [Abstract][Full Text] [Related]
36. The Complexity of Targeting PI3K-Akt-mTOR Signalling in Human Acute Myeloid Leukaemia: The Importance of Leukemic Cell Heterogeneity, Neighbouring Mesenchymal Stem Cells and Immunocompetent Cells.
Brenner AK; Andersson Tvedt TH; Bruserud Ø
Molecules; 2016 Nov; 21(11):. PubMed ID: 27845732
[TBL] [Abstract][Full Text] [Related]
37. In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche.
Zong H; Sen S; Zhang G; Mu C; Albayati ZF; Gorenstein DG; Liu X; Ferrari M; Crooks PA; Roboz GJ; Shen H; Guzman ML
Leukemia; 2016 Jul; 30(7):1582-6. PubMed ID: 26669973
[No Abstract] [Full Text] [Related]
38. Bone marrow neoplastic niche in leukemia.
Azizidoost S; Babashah S; Rahim F; Shahjahani M; Saki N
Hematology; 2014 Jun; 19(4):232-8. PubMed ID: 23905984
[TBL] [Abstract][Full Text] [Related]
39. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
Sarkaria SM; Decker M; Ding L
Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow microenvironment: The guardian of leukemia stem cells.
Houshmand M; Blanco TM; Circosta P; Yazdi N; Kazemi A; Saglio G; Zarif MN
World J Stem Cells; 2019 Aug; 11(8):476-490. PubMed ID: 31523368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
